MedPath

Functional drink NE-S01 in improving wellbeing and stamina

Phase 1
Conditions
Health Condition 1: E119- Type 2 diabetes mellitus without complications
Registration Number
CTRI/2019/12/022553
Lead Sponsor
aturedge Beverages Pvt Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Subject of age 18 to 60 years has a B.W in between 45 to 75 kg.

2. Subject is a non-smoker.

3. Subject is in good health and appropriate for exercise.

4. Subjects with diabetes mellitus type 2 with fasting blood sugar

between 120-180 mg/dl with or without ongoing oral hypoglycemic

agents

5. Subject agrees to not use any new vitamins and/or minerals until

after study completion and to not take any vitamins and/or minerals

24 hours prior to the test visits.

6. Subject agrees to not use any dietary or herbal supplements until

after study completion. A 7-day washout is allowed for study

inclusion.

7. Subject is willing and able to comply with the protocol including:

Attending 3 visits; Refraining from caffeine, over-the-counter

medications and alcohol for the 24 hours prior to the test visits;

Refraining from taking any dietary or herbal supplements throughout

the study.

8. Subject is able to understand and sign the informed consent to

participate in the study.

Exclusion Criteria

The subjects will be excluded based on the following criteria during

screening and during the study.

1. Subjects with or prior history or presence of clinically significant

Cardiovascular, pulmonary, hepatic, renal, hematological,

gastrointestinal, endocrine, immunologic, dermatologic,

musculoskeletal, neurological or psychiatric disease.

2. Subject has any orthopedic problem(s) or history of

musculoskeletal injury(ies).

3. Subject has a history of cancer (except localized skin cancer

without metastases) within 5 years prior to screening.

4. No prescription or chronic medication use allowed without PI

discretion.

5. Subject has an allergy to any of the ingredients in the test product.

6. Subject is currently taking and unwilling to refrain from taking any

over-the-counter stimulant medications/ supplements; seven-day

washout required for study inclusion.

7. Subject is currently taking and unwilling to refrain from taking any

over-the-counter allergy or asthma medication containing

pseudoephedrine or ephedrine; seven-day washout required for

study inclusion. 8. Subject reports being a regular caffeine consumer

defined as consuming > 600 mg of caffeine per day. 9. Subject has a

clinically relevant abnormality as defined by the PI or interpreting

physician with respect to the physical examination.

10. Subject has a history of drug or alcohol abuse in the past 12

months.

11. Subject has any condition or abnormality that, in the opinion of

the investigator, would compromise the safety of the subject or the

quality of the study data.

12. Subject with type 1 diabetes

13. Subjects receiving insulin

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath